Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BG00011 versus placebo in idiopathic pulmonary fibrosis
MOH_2021-07-04_002525Phase 2Completed
- Sponsor
- Biogen
- Start
- Dec 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in idiopathic pulmonary fibrosis (IPF) comparing BG00011 with Placebo (2 arms). Started Dec 2018; status: completed.
02
Drugs
STX-100
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on MOH_2021-07-04_002525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-07-04_002525.